Menoza, Neljon Fel G.
HRN: 22-40-37 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/31/2022
CEFUROXIME 750MG (VIAL)
12/31/2022
01/07/2023
IV
750mg
Q8h
Fracture, Laceration, Abrasion
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes